Efecto terapéutico de la biomodulina T homeopática con pacientes portadores de enfermedad pulmonar obstructiva crónica / Therapeutic effect of homeopathic biomoduline T, on senior adult patients with chronic obstructive pulmonary disease

Se realizó un Ensayo Clínico Controlado, fase II, aleatorizado y abierto en el Centro de Investigaciones sobre Longevidad, Envejecimiento y Salud, durante el período comprendido entre el año 2008 y 2009, con el objetivo de evaluar el efecto terapéutico de la Biomodulina T en presentación homeopática, con pacientes adultos mayores portadores de Enfermedad Pulmonar Obstructiva Crónica que sufrieran infección respiratoria a repetición. Se incluyó 100 pacientes, que dieron su consentimiento informado. Se distribuyeron en dos grupos: uno, recibió el tratamiento en estudio y el otro, el tratamiento control. La variable principal de respuesta fue la incidencia y severidad de sepsis respiratoria, durante y después del tratamiento. Se utilizó el paquete estadístico SPSS versión 13. La Biomodulina T en presentación homeopática tuvo buen efecto terapéutico en la reducción de infecciones respiratorias, así como en la disminución de las recidivas. Logró mejorar la comorbilidad en estos pacientes y mostró baja frecuencia de aparición de reacciones adversas.

A randomized, open, controlled Phase II Clinical Trial was perfomed at the Center of Investigations about Longevity, Aging and Health, from 2008 to 2009, aimed at assessing the therapeutic effect of Biomoduline T in homeopathic presentation, on senior adult patients with Chronic Obstructive Pulmonary Disease and suffering from recurrent respiratory infections. The study involved 100 patients, who gave their consent informed. The patients were equally distributed into two groups, one group received the trial treatment and the other the control treatment. The main response variable was the incidence and severity of respiratory sepsis, during and after the treatment. SPSS v. 13 statistical pack was used. Biomoduline T in homeopathic presentation had a good therapeutic effect on reducing respiratory infections and decreasing the recidives. It did improve the comorbility in these patients and showed low frequency in the apparition of adverse reactions.

Observation of Therapeutic Effect of Compound Glycyrrhizin Combining Artificial Liver on Severe Hepatitis / 中国药房

OBJECTIVE:To investigate the effect of compound glycyrrhizin(SNMC)combining artificial liver on severe hepatitis.METHODS:58patients with severe hepatitis were randomly divided into two groups,for the control group,apart from the basic treatment,each of them was also given plasmapheresis or hemoperfusion every3d～5d for5～10times ac?cording to their state of illness;For the treatment group,they were treated with SNMC apart from the therapy of the control group.RESULTS:The total effective rates of the treatment group and the control group were64.52%and40.74%,respec?tively,thus significant differences existed between the2groups(P